• Nie Znaleziono Wyników

Letter from Editor-in-Chief

N/A
N/A
Protected

Academic year: 2022

Share "Letter from Editor-in-Chief"

Copied!
1
0
0

Pełen tekst

(1)

Letter from editor-in-Chief

Dear Readers,

This is my great privilege to deliver to you the very first issue of Arterial Hypertension that I have been entrusted the responsibility for.

Facing the expiry of term of the former Editor-in-Chief Professor Krystyna Widecka, Board of Polish Society of Hypertension accepted my vision and plans focused on our Journal development. Within the next 4 years I will strive to vastly improve visibility of our Journal, and to make way for further indexations in large databases.

I cordially invite the authors from Poland and neighboring countries to dis-

seminate your work via our platform. This will not only help to strengthen our position but also facilitate tightening our bonds on the scientific grounds.

As I reviewed all articles published in Arterial Hypertension for the last three years I believe that some valuable works have still a very strong citation potential. I therefore encourage the authors to bring them back to light and cite them upon closest convenient occasion. Of more, back in 2019 two essential docu- ments were publicized in Arterial Hypertension i.e.: Polish Society of Hypertension official guidelines on the management of hypertension, and the position paper coordinated by three influential medical societies. The latter comprehensively clarifies aspects of hypertension management in pregnancy. I kindly invite you to recollect these extremely important statements, what has been made easy for you, as both are open access documents. Therefore, including these references in your manuscripts would be of huge benefit for our Journal.

Taking this rare opportunity of a first letter from Editor-in-Chief I would like to share just one closing remark with you. I want to warmly invite you to start or continue the cooperation with us. It is very likely that with your even minimal input we can get wider visibility in the world’s scientific community.

Let’s make this happen, together.

Jacek Wolf, M.D., Ph.D.

Editor-in-Chief ‘Arterial Hypertension’

March 31, 2021

Cytaty

Powiązane dokumenty

At the beginning of October, annual meeting of European Association for the Study of Diabetes (EASD) will be held in Berlin, and one of the most awaited events during this

Among papers included in this issue of “Clinical Diabetology”, it is worth paying attention to a multi- centre study conducted in 2013–2017 in women with type 1 diabetes who,

As the practical management of patients with diabetes should be based primarily on knowledge derived from Evidence Based Medicine (EBM), the reference to the EBM

I would like to draw your attention to the problem of diabetes care quality discussed by researchers from Libya, an interesting case report of the use of hydroxychloroquine in type

Many interesting reports presented during the Congress addressed, among others, epidemiology, new possibilities of molecular biology, measurable effects of translating basic

Following the publication of the results of already completed Cardiovascular Outcome Trials (CVOTs) on new molecules used in the treatment of diabetes, there is no doubt that

In the InTandem3 study (Study to Evaluate the Safety of So- tagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycaemic Control With Insulin Therapy Alone) with

In addition to attending the scientific meetings, I also encourage you to read the latest issue of the “Clinical Diabetology”, where, among a number of interesting articles, I would